Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07850960) titled 'Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Federal State Budgetary Scientific Institution
Condition:
Obesity & Overweight
Gastroesophageal Reflux Disease
Intervention:
Drug: Omeprazole
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 25, 2026
Target Sample Size: 26
Countries of Recruitment:
Russia
To know more, visit https://clinicaltrials.gov/s...